(1R,2R,4S)-9-(2-HYDROXY-4-[(4,4'-DIMETHOXYTRITYL)-OXY]-CYClOPENT-1-YL)-9H-ADENINE
Compound with spectra: 1 NMR
![(1R,2R,4S)-9-(2-HYDROXY-4-[(4,4'-DIMETHOXYTRITYL)-OXY]-CYClOPENT-1-YL)-9H-ADENINE](/api/compound/9SdZj410YCZ.png?ph=true&h=300&w=458 "(1R,2R,4S)-9-(2-HYDROXY-4-[(4,4'-DIMETHOXYTRITYL)-OXY]-CYClOPENT-1-YL)-9H-ADENINE")
| SpectraBase Compound ID | 9SdZj410YCZ |
|---|---|
| InChI | InChI=1S/C31H31N5O4/c1-38-23-12-8-21(9-13-23)31(20-6-4-3-5-7-20,22-10-14-24(39-2)15-11-22)40-25-16-26(27(37)17-25)36-19-35-28-29(32)33-18-34-30(28)36/h3-15,18-19,25-27,37H,16-17H2,1-2H3,(H2,32,33,34)/t25-,26+,27+/m0/s1 |
| InChIKey | XXNSIVUIZZYBFZ-OYUWMTPXSA-N |
| Mol Weight | 537.62 g/mol |
| Molecular Formula | C31H31N5O4 |
| Exact Mass | 537.237604 g/mol |
| Enantiomer InChIKey | XXNSIVUIZZYBFZ-PVHODMMVSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
9-[3.beta.-Acetamido-2.beta.-hydroxy-4.alpha.-(hydroxymethyl)cyclopent-1.alpha.-yl]adenine
9-((1R,2R,3S)-TETRAHYDRO-2-HYDROXY-3-(((4-METHOXYPHENYL)-DIPHENYLMETHOXY)-METHYL)-1-FURANYL)-9H-ADENINE
4-(ADENIN-9-YL)-1,6-ANHYDRO-2,4-DIDEOXY-BETA-D-ARABINOHEXOPYRANOSE
1,2,3,5,6-TETRA-O-ACETYL-4-(ADENIN-9-YL)-2,4-DIDEOXY-D-ARABINOHEXITOL
9-[(1'.beta.,3'.alpha.,4'.beta.)-4'-(tert-Butyldimethylsilyloxy)-2',3'-dihydroxycyclopentyl]-6-chloropurine
FSURNZBYIMEAJA-JHJVBQTASA-N
(1S,2R,4R)-4-(2,6-DIAMINO-9H-PURIN-9-YL)-2-[(TRIPHENYLMETHOXY)-METHYL]-CYCLOPENT-1-YL-TRIETHYLAMMONIUM-SULFATE
5'-O-(TERT.-BUTYLDIMETHYLSILYL)-3'-DEOXY-3'-FLUOROADENOSINE
9-[5-O-(TERT.-BUTYLDIMETHYLSILYL)-3-DEOXY-3-FLUORO-BETA-D-XYLOFURANOSYL]-ADENINE
5'-S-PROPIONYL-5'-THIOADENOSINE
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of (+)-5'-nor-2'-deoxyaristeromycin and (-)-5'-nor-3'-deoxyaristeromycin | The Journal of Organic Chemistry | 1993 |